Skip to content
Licitop.eu

PNSP 26/2026 Adquisición de los principios activos Vismodegiv, Emicizumab, Trastuzumab-Emtansina, Rituximab, Ocrelizumab, Pertuzumab+Trastuzumab, Atezolizumab, Faricimab, Vemurafenib (ROCHE FARMA SA ) para la GAI de Guadalajara.

Awarded Contract award Save

Description

Id licitación: 2026/001437; Órgano de Contratación: Gerencia del Area de Atención Integrada de Guadalajara; Importe: 4795323.69 EUR; Estado: RES

Official source

Source: PLACSP - Plataforma de Contratación del Sector Público

Always verify details on the official notice.

View the official notice

More from this buyer

Full buyer profile

Recent awards

Similar tenders

Never miss a tender like this

Get an email for new tenders matching: Medical equipment & pharmaceuticals · Spain. Free.

Set up my alert